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Abstract
Background: Despite recent advances in surgical 
t echn iques  and  per iopera t ive  management , 
postoperative infectious complications remain 
a problem in surgical patients. We performed a 
prospective randomized clinical trial to examine the 
effects of preoperative Immune Enhancing Diets (IEDs) 
on postoperative complications in Japanese patients 
who underwent curative colorectal cancer surgery. 
This study was also designed to evaluate the optimal 
dose of preoperative IEDs for the patients without 
malnutrition. Finally, we analyzed recurrence free 
survival (RFS) and disease-specific survival (DSS) after 
surgery in patients who did and did not receive IEDs
preoperatively.
Material and Methods: This was a prospective, 
randomized clinical trial conducted at the Department 
of Surgery, National Defense Medical College, 
from October 2002 to October 2005. The 88 patients 
undergoing colorectal surgery were enrolled and were 
randomly divided into 3 groups. The high- (High, N=26) 
and low- (Low, N=31) dose groups received normal food 
and, respectively, 750ml/day or 250ml/ day of IEDs for 5 
days before the operation. The primary endpoint was the 
rates of surgical site infection (SSI) and non- infectious 
complications. We also evaluated the RFS and DSS rate, 
respectively. 
Results: The patients were followed for 77±10 months 
(9-133 months) after surgery. Incisional SSI rates in the 
IEDs (High and Low) groups were significantly lower 
than in the Control group. (0%*, 0%* and 17%) (*P<0.01 
vs. Control) The incidences of the infections not involving 
the surgical site (non-SSI) and the lengths of hospital 
stay were similar among the three groups. No significant 
differences were observed in RFS or DSS.
Conclusion:  In Japanese patients undergoing 
colorectal cancer surgery, preoperative IEDs significantly 
reduced the rate of incisional SSI as compared with the 
control group. Very interestingly, in Japanese patients, 
preoperative 250ml/day IED intake may be adequate for 
colorectal cancer patients without malnutrition. However, 
with regard to the long term outcome, beneficial effects of 
preoperative IEDs are not evident. 
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Patients. Gastroenterology and Hepatology, 2 (1), 1-8. Available 
from: http://www.cscanada.net/index.php/css/article/view/5459 
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INTRODUCTION
Despite recent advances in surgical techniques and 
perioperative management, postoperative infectious 
complications remain a problem in surgical patients. 
Once this infectious complication has occurred, it 
increases medical costs, worsens quality of life for 
patients and prolongs hospitalization in the short term. 
Postoperative infectious complications may delay the 
initiation of adjuvant therapy or modify the systemic 
inflammatory response and provide favorable conditions 
for tumor growth, resulting in poor long term outcomes.
[1-3] Among infectious complications, with colorectal 
surgery especially, surgical site infection (SSI) is a 
frequent cause of morbidity with an incidence of up to 
30% in previous studies.[4-6] Decreasing postoperative 
infect ious complicat ions are  thus an important
issue.
With the advent of novel nutritional formulas 
containing agents that modulate the immune system, such 
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as glutamine, arginine, n-3 fatty acids and RNA, a new era 
of nutritional therapy began almost two decades ago. The 
European Society for Parenteral and Enteral Nutrition 
(ESPEN) guidelines[7], published in 2006, recommend 
an immunomodulating formula (enriched with arginine, 
omega-3 fatty acids, and nucleotides), especially for 
patients with an obviously severe nutritional risk and 
those who underwent major surgery. To date, randomized 
clinical studies have shown preoperative Immune 
Enhancing Diets (IEDs) containing arginine and ω-3 
fatty acids to be useful for improving the immunological 
response and for decreasing infection rates after 
resection of colorectal and other gastrointestinal cancers.
[8-9]  However, nearly all of these studies were conducted 
in western countries.
In Japan, since an enteral diet was introduced for 
immunonutrition in 2002, many reports have examined 
the preventive effects of enteral diets on infectious 
complications in patients undergoing gastrointestinal 
surgery. However, there are only a few Japanese reports 
focusing on colorectal surgery.[10]  Moreover, to the best of 
our knowledge, the effects of preoperative intake of IEDs 
on long-term outcomes of cancer surgery have not yet 
been reported. 
We performed a prospective randomized clinical trial to 
examine the effects of preoperative IEDs on postoperative 
complications in Japanese patients who underwent 
curative colorectal cancer surgery. This study was also 
designed to evaluate the optimal dose of preoperative 
IEDs for patients without malnutrition undergoing elective 
colorectal resection. Finally, we analyzed recurrence free 
survival (RFS) and disease-specific survival (DSS) after 
surgery in patients who did and did not receive IEDs 
preoperatively. 
MATERIALS AND METHODS
Patients and Clinical Protocol 
This was a prospective, randomized clinical trial 
conducted at the Department of Surgery, National 
Defense Medical College in Tokorozawa Saitama 
Japan. From October 2002 to October 2005, 88 
patients undergoing colorectal surgery were enrolled 
in this clinical study. The exclusion criteria were age 
younger than 18 years, active preoperative infection, 
administration of corticosteroids or other immune-
suppressive agents,  gastrointestinal obstruction, 
respiratory dysfunction (arterial PaO2<70mmHg), 
cardiac dysfunction (New York Heart Association 
class>3), renal failure (serum creatinine >3mg/dl 
or hemodialysis), hepatic dysfunction (Child-Pugh 
grade C), history of recent immunosuppressive or 
immunologic diseases, and preoperative evidence of 
widespread metastatic disease. The study protocol was 
performed following the approval of the Institutional 
Review Board of the National Defense Medical College 
and was registered in the University Hospital Medical 
Information Network (UMIN) database (ID 000012679). 
The subjects were enrolled in the current study only 
when wrote informed consent was obtained from the 
patient and/or from family members, once the study 
protocol had been explained in detail. After enrollment, 
the secretary of the surgical department opened a sealed 
opaque envelope and randomized the patients into the 
control or trial groups. The 88 patients were randomly 
divided into 3 groups. The high- (High, n=26) and 
low- (Low, n=31) dose groups received normal food 
and, respectively, 750 ml/day or 250 ml/ day of IEDs 
enriched with arginine, omega-3 fatty acids and RNA 
(oral IMPACT®; Ajinomoto Pharma Co., Ltd, Tokyo, 
Japan) for 5 days before the operation. The constituents 
of IMPACT® are shown elsewhere (Table 1). The control 
group (Control, n=31) was given normal food without 
an IED. The clinical protocol is shown in Figure 1. 
No patients received steroids or non-steroidal anti-
inflammatory drugs postoperatively. After the operation, 
3 patients were excluded because of non-curative
resection. 
Table 1  
Composition of IMPACT®
Amount (per100ml)
Energy  (kcal)
Protein (g)
Fat (g)
Eicosapentaneoic acid (g)
Docosahexaenoic acid (g)
n-6:n-3 ration
Carbohydrate (g)
Arginine (g)
RNA (mg)
101
5.6
2.8
0.20
0.14
4:5
13.4
1.28
0.13
operation
High  Group 
Low   Group
750 ml/ day  IMPACT +  normal food
i
Control Group
250 ml/ day  IMPACT +  normal food
Pat ents
-6 -5 -4 -3 -2 -1
normal food
5 Days
(IMPACT® Aji t Ph T k J ), nomo to arma o yo, apan )
Clinical protocol 
Figure 1
Flow Diagram of the Study Protocol  
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Figure 2 shows the patient distribution of this analysis.
Figure 2
Patient Distribution
Surgical Procedure
The anesthesia, surgical procedure, and postoperative care 
following colorectal cancer surgery are standardized in 
the National Defense Medical College.[11-12] All patients 
underwent elective resection of the colon and rectum 
via laparotomy. Mechanical bowel preparation was 
performed in all the patients. No patients in any of the 
groups received preoperative oral antibiotics. Single-
shot antibiotics (1g cefmetazole IV) were routinely used 
for infection prophylaxis and were given during induction 
of anesthesia and repeated every 4 hours during surgery. 
Administraion of antibiotics was continued twice a day 
for 3 days after surgery. Before closing the abdomen, the 
abdominal cavity was washed with 3,000 ml of warm 
saline. The pathological classification of the primary 
tumor, the degree of lymph node involvement, and the 
presence of organ metastasis were characterized according 
to the TNM/UICC classification. 
Measurement of Nutritional Variables and Blood 
Biochemical Examinations
The WBC and serum C-reactive protein (CRP) levels 
were measured preoperatively and at 1, 4, and 7 days after 
surgery. Before and after administration of the IEDs, the 
following parameters were determined in all patients: 
The total protein (TP), albumin (Alb), total cholesterol 
(TCHO), glutamic oxaloacetic transaminase (GOT), 
glutamic pyruvic transaminase (GPT), blood urinary 
nitrogen (BUN), creatinine (CRE) and cholinesterase 
(ChE) concentrations in serum and total lymphocyte count 
(P-LYMPH).
Definitions of Infectious and Other Complications
We analyzed the data for age, sex, height, weight, body 
mass index (BMI), cancer site and stage, operative 
procedures on the rectum, and operative time and blood 
loss. Postoperative complications were defined in the 
following manner. SSI was diagnosed according　to 
CDC definitions of nosocomial SSI.[13] SSI are divided 
into incisional SSI and organ/space SSI. Organ/space 
SSI included intra-abdominal or pelvic abscess and 
anastomotic leakage. Follow-up for SSI was performed 
during office visits for 30 days after hospital discharge. 
Non-SSI was defined as an infection in an organ 
remote from the surgical site, e.g., urinary tract 
infection, pneumonia, and so on. The length of stay 
(LOS) was defined as the number of days from the day 
of the operation until the date of discharge. Systemic 
inflammatory response syndrome (SIRS) was diagnosed 
by the presence of two or more of the following: body 
temperature >38℃ or <36℃; heart rate > 90 beats/min; 
respiratory rate > 20 beats/min or PaCO2 < 32 torr; and 
white blood cell (WBC) count > 12,000 or < 4,000 cells/
mm3 or > 10% immature band forms at 1, 4, and 7 days 
after surgery.14 We evaluated the rates of RFS and DSS 
after surgery.　The RFS was defined as the interval 
between the date of surgery and the date of recurrence. 
Date of recurrence was established by radiographic 
studies, laboratory studies, physical examination, and/
or histopathology. The DSS was calculated from the date 
of surgery to the time of last visit or cancer specific death. 
Follow-up was updated in October 2013 for the current 
study.
Statistical Analysis
The primary endpoint was the incidence of SSI. 
Seconda ry  ob jec t ives  were  r a t e s  o f  non-SSI , 
perioperative morbidity, LOS and highest CRP value 
or WBC count on day 1, 4 or 7 after surgery. All data 
except LOS are expressed as the mean ± standard 
error of the mean for each group. LOS was defined 
as the median value in days. Statistical significance 
was determined using analysis of variance (ANOVA) 
followed by the post hoc test of Fisher’s protected 
least significant difference. The Chi-square test was 
used for comparison of the incidence of postoperative 
complications. A minimum sample size required 30 
patients in each arm to insure 80% power at the 5% 
significance level for detecting a 20% improvement 
in the incidence of postoperative complications from 
5% to 25%. Each variable affecting the survival rate 
was estimated using the Kaplan–Meier method. The 
significance of differences in RFS and DSS between 
subgroups was calculated using the log-rank test. P < .05 
considered statistically significant.
RESULTS
The clinical background factors of all patients are 
summarized in Table 2. No significant differences 
were observed in age, gender, height, body weight or 
BMI.
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Table 2
Clinical Characteristics of the Three Groups
High Low Control
N 26 30 29
Age (yrs) 64.7±2.3 64.8±2.3 63.8±2.0
Male
Female
15
11
19
11
18
11
Height (cm) 159±1.8 159±2.1 160±1.8
Weight (kg) 57.3±2.3 56.8±2.3 57.1±2.2
 BMI 22.6±0.8 22.0±0.7 22.2±0.6
Change in Nutritional Parameters After 5 days of IEDs 
intake (Table 3)
Table 3
Nutritional Parameters and Biochemical Examination 
of Blood
High Low Control
Pre　 BW(kg)
Post　BW(kg)
57.3±2.3
57.3±2.2
56.8±2.3
56.6±2.2
57.1±2.2
56.9±2.1
Pre  P-LYMPH(/mm3)
Post  P-LYMPH(/mm3)
1340±110
1470±140
1400±90
1440±90
1610±150
1740±160
Pre Alb(g/dl)
Post Alb(g/dl)
4.1±0.1
4.1±0.1
4.1±0.1
4.2±0.1
4.2±0.1
4.2±0.1
Pre ChE (IU/l)
Post ChE (IU/l)
1600±70
1610±70
1540±50
1560±50
1570±60
1590±60
Pre GOT(IU/l)
Post GOT(IU/l)
22.2±1.6
22.7±1.6
20.0±1.2
19.7±1.0
24.0±1.7
23.7±1.6
Pre GPT(IU/l)
Post GPT(IU/l)
19.6±2.4
24.9±2.8
19.4±2.1
19.5±2.4
23.5±2.5
22.9±2.5
Pre BUN(mg/dl)
Post BUN(mg/dl)
14.6±0.9*
16.7±1.0
12.3±0.6
13.0±0.8#
14.9±0.5*
13.1±0.7#
Pre CRE(mg/dl)
Post CRE(mg/dl)
0.78±0.03
0.76±0.03
0.75±0.03
0.73±0.03
0.76±0.03
0.77±0.03
Pre TP(g/dl)
Post TP(g/dl)
6.8±0.1
6.9±0.1
6.7±0.1
6.6±0.1
6.9±0.1
6.9±0.1
 Pre TCHO(mg/dl)
Post TCHO(mg/dl)
195.0±7.4
193.8±8.3
196.5±5.5
199.0±5.1
207.2±9.9
202.3±10.0
Note. BW; Body weight, P-LYMPH; peripheral lymphocytes, 
Alb; albumin, ChE; cholinesterase, GOT; glutamic oxaloacetic 
transaminase, GPT; glutamic pyruvic transaminase, BUN;blood 
urinary nitrogen, CRE; creatinine, TP; Total protein, TCHO; Total 
cholesterol; Values are mean±S.E  * P<.01 vs Low #P<.01 vs
High
Compliance with the administration of IEDs in 
the High and Low groups was excellent, because all 
patients allocated to the IEDs groups could drink the full 
amounts of IEDs prescribed. During the preoperative 
period, none of the patients in either group developed 
adverse gastrointestinal effects associated with the 
immunonutrition. P-Lymph, Alb, ChE, BUN, CRE, TP 
and TCHO before and after 5-days IEDs intake are shown 
in Table 3. Before IEDs intake, BUN was lower in the 
Low than in the other two groups. After administration, 
BUN was higher in the High than in the other two groups. 
No parameters except BUN showed any significant 
difference before versus after IEDs intake in the three 
groups.　
The three groups were comparable in terms of 
pathological stage, tumor location, operative method for 
rectal cancer, intraoperative blood loss and operative time. 
The numbers of patients given preoperative chemotherapy 
and/or radiotherapy were similar among the three groups.
 Table 4 
Surgical Baseline Characteristics of the Three Groups
High Low Control
Stage
0/Ⅰ/Ⅱ/Ⅲa/Ⅲb 0/9/9/6/2 0/10/11/6/3 2/7/15/4/1
Location
Colon/Rectum 10/16 14/16 17/12
Rectum
LAR/sLAR/APR 5/9/2 9/7/0 4/5/3
Operative time 
(min) 246±22 222±18 223±16
Operative blood loss 
(ml) 540±174 350±70 297±63
Pre chemotherapy
 and/ or radiation 9 7 7
Note. Values are mean±S.E,  LAR: low anterior resection, sLAR: 
super low anterior resection, APR: abdominoperineal resection
Effects of IEDs on Postoperative WBC Counts and 
Serum CRP Levels
WBC counts and CRP levels in the postoperative period 
are shown in Figures 3 and 4. At day 7, the WBC count 
was lower in the Low than in the Control group. There 
were no differences among the groups in CRP levels at 
any time point.
Figure 3 
WBC Counts in the Postoperative Period
Note. Values are means±SE  , *P<.05 vs. Control at day 7 ANOVA
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Figure 4
CRP levels in the Postoperative Period
Surgical Outcomes
Postoperative complications, the duration of SIRS and 
LOS are summarized in Table 5. Incisional SSI rates 
were 0%*, 0%* and 17% (5/29) (*P<.01 vs. Control) in 
the High, Low and Control groups. The rates of organ/
space SSI were 12% (3/26), 0% and 11% (3/29). The 
incidences of non-SSI and LOS were similar among the 
three groups. In the IEDs group, the duration of SIRS 
tended to be shorter than in the Control group, but the 
difference did not reach statistical significance (P=.08). 
No patient died while in the hospital in any of the three 
groups.
Table 5 
Surgical Outcome
High Low Control
Number 26 30 29
Infectious 
complication 5 2 8
Incisional SSI 0 * 0 *
5 ( 17%)
Wound infection 
5
Organ/space SSI
3 ( 12%)
Anastomotic 
leakage 2
Intra-abdominal 
abscess1
0 
3 ( 11%)
Anastomotic 
leakage 3
Non-SSI 2 ( 8%)Urinary tract 2
2 ( 7%)
Urinary tract 2
2 ( 7%)
Urinary tract 2
Noninfectious
complication
4 ( 15%)
Ileus 2
Stoma necrosis 1
Urinary 
disturbance 1
5 (17%)
Ileus 2
Thrombosis 1
Lymphocele 1
Urinary 
disturbance 1
1 ( 3%)
Ileus 1
SIRS (day) 0.28±0.1 0.20±0.1 0.50±0.1
LOS (day) 16 16.5 16
Note. Values are mean±S.E, * P<.01 vs control
Impact of preoperative IEDs on RFS and DSS (Figure 5)
The patients were followed for 77±10 months (9-133 
months)after surgery. The 5-year RFS rates were 85, 73 and 
86%, in the High, Low and Control groups, respectively. 
The 5-year DSS rates were 89, 93 and 93%, respectively. 
No significant differences were observed in RFS or DSS.
Figure 5 
RFS and DSS After Surgery With Curative Intent for Colorectal Cancer
DISCUSSION
The present study demonstrated preoperative IEDs to 
significantly reduce the rate of superficial incisional 
SSI as compared with the control group and a trend 
towards shorter duration of SIRS than with conventional 
management was also noted. In addition, the Low 
dose IEDs group had no complications involving 
organ/specific SSI. On the other hand, preoperative 
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administration of IEDs did not reduce the morbidity of 
non-infectious complications, nor did it affect RFS or 
DSS, in cancer patients.
In the present study, incisional SSI was significantly 
less frequent in the IEDs groups than in the Control 
group. Although the IEDs were provided in addition to 
normal foods, there were no significant differences in 
nutritional parameters among the groups. Therefore, the 
beneficial effects of IEDs on SSI were possibly due to 
their pharmacological actions rather than improvements 
in nutritional status. Several groups have reported the 
beneficial effects of preoperative IEDs on the prevention 
of incisional SSI in gastrointestinal cancer surgery. Horie 
et al reported favorable effects of preoperative enteral 
immunonutrition on SSI in patients with colorectal 
cancer without malnutrition[10]. Horie et al conducted 
a prospective study to ascertain the effects of 
preoperative 5-day enteral immuno-nutrition on SSI in 
colorectal cancer patients without malnutrition. They 
demonstrated the frequencies of superficial incisional 
SSI to be 0% and 11.8% in the immunonutrition and 
control groups, respectively. Shirakawa et al also showed 
effectiveness for preventing incisional wound infection in 
patients undergoing pancreaticoduodenectomy, with the 
frequency of incisional wound infection being lower in 
the IEDs than in the control group. (0 vs. 30.8%)[15]  In the 
present study, the IEDs and Control groups had 0% (Low 
+ High) and 17% (5/29) incisional SSI rates, consistent 
with the findings of prior studies. Because the incisional 
SSI rates in colon and rectal surgeries without IEDs are 
reportedly 9.4% and 18.0% in Japan[4], the incisional SSI 
rate in our control group appears to be valid. Preoperative 
oral IEDs, such as Impact, may be important for 
preventing incisional wound infection not only in Western 
but also in Japanese patients.  
The optimal quantity of preoperative IEDs intake has 
also been a matter of debate. To date, many studies have 
adopted an IEDs volume of 500-1,000 ml/ day.[8-9,16-18] 
Braga et al prescribed 1,000ml/day of IEDs to patients 
without malnutrition, and the actual mean intake was 
890 ml.[19] When compared with Western patients, body 
weights of Japanese patients are generally low. Thus, we 
chose 750 ml/ day and 250ml/ day intakes for the two 
IEDs groups. Indeed, Horie et al reported that compliance 
with 1,000 ml/day IEDs intake is very low, at <50%, in 
Japanese patients [10]. They concluded the preoperative 
5-day administration of IMPACT Japanese version (750 
ml/day) to be effective in preventing SSI. Nakamura et al 
also showed low compliance (60%) of patients receiving 
1000ml/day of IEDs and recommended an intake of 500 
ml/day as an optimal dose.[20]  
 Interestingly, even the 250ml /day IEDs intake 
could reduce the rates of  incisional  and organ/
specific SSI. This dose is far lower than those reported 
previously. One possible reason for such a small dose 
being effective may be the healthy dietary lifestyles 
of Japanese people. Because Japanese people tend to 
consume more fish than Western populations, with fish 
consumption in Japan being approximately double that in 
other countries [21-22], the serum level of 3 fatty acids, one 
of the immunonutrients in IMPACT, may have already 
been relatively high as compared with Western patients 
even before hospital admission. In addition, the food 
served during hospitalization may include meals rich 
in 3 fatty acids, while 6 fatty acids might be restricted. 
We plan to evaluate serum fatty acid profiles in a future 
study. 
Interestingly, the number of organ/space SSI was 
decreased in the low-intake group whereas an increase 
was observed in the high-intake group. The organ/
space SSI in the high-intake group were due to major 
anastomotic leakage, suggesting that we cannot expect 
IEDs to prevent SSI due to serious technical problems 
with the surgical procedure. Although there were no 
statistically significant differences in the percentages 
of operative procedures for rectal cancer among the 
3 groups, the High group included somewhat more 
sLAR cases than the other two groups (Cases of sLAR: 
High 9 , Low 7, Control 5).  Thus, this may account for 
the higher incidence of organ/space SSIs in the High 
group.
Compliance with preoperative IEDs intake was 
excellent and there were no adverse side effects such as 
nausea, vomiting and diarrhea. However, serum BUN 
after 5-day intake was higher in the High than in the other 
two groups. This finding suggested that 750ml/ day IEDs 
intake may be an excessive renal burden in patients who 
simultaneously consume regular meals. Indeed, Suzuki D 
et al., who showed the beneficial effects of perioperative 
IEDs in patients receiving pancreaticoduodenectomy, 
reduced the amount of ordinary diets by half in their 
IEDs group.[17] The patients in the IEDs group consumed 
1,000ml/day before surgery for 5 days. Thus, it is possible 
that 250 ml/day IED intake is adequate for well-nourished 
patients who can consume all regular meals. 
We analyzed RFS and DSS after surgery in patients 
who did and did not receive IEDs preoperatively. It is 
very disappointing that preoperative IEDs had no impact 
on RFS or DSS after colorectal surgery in these patients. 
We can speculate as to possible mechanisms underlying 
this lack of beneficial effects. In the present study, 
preoperative IEDs prevented incisional SSI only, not 
major complications, such as anastomotic leakage which 
has the effect of upstaging the disease and increasing the 
incidence of locoregional relapse.[23] Indeed, the presence 
of incisional SSI did not prolong LOS, suggesting that 
this type of infection may not have a major impact on host 
tumor immunity in Japanese patients who generally have 
a thin layer of abdominal wall fat. Tsujimoto et al also 
showed anastomotic leakage to be the strongest predictor 
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of a poor outcome, while wound infection was not 
associated with either cancer-specific survival or overall 
survival. [24-25]  
This study has limitations. First, the number of patients 
recruited for this study is relatively small. Second, 
various staff members performed the surgeries. Therefore, 
differences in surgical skill among these surgeons might 
have affected the incidence of postoperative infectious 
complications. Finally, Japanese people generally 
consume larger amounts of -3 fatty acids from fish than 
Western populations. Therefore, -3 fatty acid levels in 
plasma may have differed markedly among the patients in 
this study, which could have affected clinical outcomes. 
However, we did not evaluate plasma fatty acid profiles 
during the perioperative period.
In conclusion, in Japanese patients undergoing 
colorectal cancer surgery, preoperative IEDs significantly 
reduced the rate of incisional SSI and showed a trend 
towards shorter duration of SIRS as compared with the 
control group. Very interestingly, in Japanese patients, 
preoperative 250ml/day IEDs intake may be adequate for 
colorectal cancer patients without malnutrition. However, 
with regard to the long term outcome, beneficial effects of 
preoperative IEDs are not evident.
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